Norah-Jane holds a BSc. in Pharmacology from University College Dublin and a dual International Master’s Degree in Innovative Medicine from the University of Groningen and Uppsala University. She conducted her Master’s thesis project in the Ingber Lab at the Wyss Institute, Harvard University, where she focused on novel target discovery at the blood-brain barrier. She joined the Armstrong Group as a PhD candidate in October 2022, and is working to assemble an in vitro model of the blood-brain barrier using advanced bioprinting technologies, a collaborative project with Dr Liliang Ouyang at Tsinghua University, Beijing.
Email Address: norah-jane.prendergast@bristol.ac.uk